pfizer vaccine

The FDA authorized the first COVID-19 vaccination for children as young as six months on Friday. A panel of CDC advisors will vote Saturday, meaning shots for infants and preschoolers could be available as early as next week.

An analysis from the U.S. Food and Drug Administration states that kid-sized doses of Pfizer’s COVID-19 vaccine appears safe and effective for children under five, which would be a huge step towards vaccinating the nation’s youngest children who were previously unprotected.

Pfizer says it will seek emergency use authorization for a three-dose course of its COVID-19 vaccine in pediatric patients ages 6 months to 5 years old after publishing data from it’s latest study.

The FDA announced Tuesday that it has expanded eligibility for the Pfizer booster shot to include children ages 5 to 11.

Pfizer is looking to get approval for the COVID-19 booster shot for 5-11 year-old children.

Pfizer and its partner BioNTech said Thursday new data shows its kid-sized booster shot helps healthy 5- to 11-year-olds rev up virus-fighting antibodies.

The U.N.-backed Medicines Patent Pool says that nearly three dozen companies worldwide will soon start making generic versions of Pfizer’s coronavirus pill

Pfizer asked the FDA Tuesday to authorize a second booster dose of its COVID-19 vaccine for Americans ages 65 and over.

German vaccine maker BioNTech unveiled plans Wednesday to establish manufacturing facilities in Africa that would boost the availability of much-needed medicines on the continent

The FDA and CDC granted authorization on Thursday for Pfizer’s COVID-19 booster for 16- and 17-year-olds.

Members of the White House Coronavirus Task Force spoke optimistically the day after the Pfizer vaccine earned CDC approval for children ages 5 to 11, highlighting the vaccine’s safety and efficacy and encouraging parents to get their children vaccinated.

The FDA announced Friday that it had authorized emergency use of the Pfizer coronavirus vaccine for children ages 5-11.

The Food and Drug Administration on Friday paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. The FDA cleared kid-size doses — just a third of the amount given to teens and adults — for emergency use, and up to 28 million more American children could be eligible for vaccinations as early as next week….

A new CDC study found that vaccines offer more protection from COVID-19 than antibodies from a previous infection. Researchers found that adults who had recently recovered from COVID-19 but remained unvaccinated were more than 5 times more likely to catch the coronavirus than adults who were vaccinated and had never had COVID-19.

The FDA will now consider the panel’s recommendation before authorizing the Pfizer COVID-19 vaccine for children ages 5 to 11.

Federal health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters.

Sandra Lindsay, a New York City nurse who was the first person in the U.S. to receive a COVID-19 vaccine, got her booster shot today.

Pfizer/BioNTech submitted data to the FDA Tuesday to clear its COVID-19 vaccine for use in kids ages 5-11

With more than 40 million doses of coronavirus vaccines available, U.S. health authorities said they’re confident there will be enough for every American who qualifies

Pharmaceutical giant BioNTech, which worked with Pfizer to create their mRNA coronavirus vaccine, told German news weekly Der Spiegel in an interview published Friday that it would be seeking FDA approval “over the next few weeks” for use of its vaccine in children ages 5 to 11.